153 related articles for article (PubMed ID: 16703288)
21. [Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer].
Patonay P; Naszály A; Mayer A
Strahlenther Onkol; 2007 Feb; 183(2):94-8. PubMed ID: 17294114
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiotherapy for head-and-neck cancer in the community setting.
Seung S; Bae J; Solhjem M; Bader S; Gannett D; Hansen EK; Louie J; Underhill K; Cha C
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1075-81. PubMed ID: 18486355
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
24. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
25. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI
Cancer; 2006 Sep; 107(6):1321-30. PubMed ID: 16902985
[TBL] [Abstract][Full Text] [Related]
26. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
27. Accelerated radiotherapy and larynx preservation in favorable-risk patients with T2 or worse hypopharyngeal cancer.
Kawashima M; Hayashi R; Tahara M; Yamazaki M; Miyazaki M; Arahira S; Ogino T
Jpn J Clin Oncol; 2007 May; 37(5):345-52. PubMed ID: 17584824
[TBL] [Abstract][Full Text] [Related]
28. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Healey JH; Singer S
J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
30. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
31. Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base.
Lawson JD; Otto K; Chen A; Shin DM; Davis L; Johnstone PA
Head Neck; 2008 Mar; 30(3):327-35. PubMed ID: 17657789
[TBL] [Abstract][Full Text] [Related]
32. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study.
Fiorino C; Dell'Oca I; Pierelli A; Broggi S; Cattaneo GM; Chiara A; De Martin E; Di Muzio N; Fazio F; Calandrino R
Strahlenther Onkol; 2007 Sep; 183(9):497-505. PubMed ID: 17762924
[TBL] [Abstract][Full Text] [Related]
34. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy.
Braam PM; Terhaard CH; Roesink JM; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):975-80. PubMed ID: 16965864
[TBL] [Abstract][Full Text] [Related]
36. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
Chua DT; Sham JS; Leung LH; Au GK
Radiother Oncol; 2005 Dec; 77(3):290-4. PubMed ID: 16289398
[TBL] [Abstract][Full Text] [Related]
37. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
[TBL] [Abstract][Full Text] [Related]
38. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
Webster GJ; Rowbottom CG; Ho KF; Slevin NJ; Mackay RI
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):617-22. PubMed ID: 18793966
[TBL] [Abstract][Full Text] [Related]
40. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
